Medicare Enrolled
Dr. Daniel Salcedo, MD
Physical Medicine & Rehabilitation · Williamsville, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Salcedo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Salcedo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Salcedo
Dr. Daniel Salcedo is a physical medicine & rehabilitation specialist in Williamsville, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Salcedo performed 1,651.5 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Salcedo received a total of $22,977 from 67 pharmaceutical and/or device companies across 817 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Salcedo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 37% volume in NY
$22,977 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,651.5
Medicare services
Top 37% in NY for physical medicine & rehabilitation
Not available
Unique patients (not deduplicated)
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
374 | $0 | $9 |
| Injection, methylprednisolone acetate, 40 mg | 189.5 | $6 | $8 |
| Contrast dye for imaging, lower concentration | 160 | $0 | $0 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
158 | $0 | $0 |
| Bupivacaine injection, 0.5 mg An injection of bupivacaine, a local anesthetic, administered in a dose of 0.5 mg. |
131.5 | $0 | $4 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
82 | $10 | $39 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
66 | $60 | $156 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
65 | $141 | $564 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
64 | $76 | $283 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
60 | $214 | $1,275 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
53 | $192 | $596 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
46 | $178 | $715 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
31 | $144 | $693 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
28.5 | $0 | $0 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
28 | $316 | $1,214 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
26 | $184 | $520 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
21 | $145 | $553 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
21 | $76 | $273 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
18 | $85 | $270 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $98 | $314 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
13 | $142 | $470 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
22.6% high complexity
65.1% medium
12.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,977
Total received (2018-2024)
Avg $3,282/year across 7 years
Top 2% in NY for physical medicine & rehabilitation
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
817
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,891
2023
$1,571
2022
$2,533
2021
$2,719
2020
$2,011
2019
$4,464
2018
$4,788
Payments by company (2024)
Spinal Simplicity, LLC
$1,439
SI-BONE, INC.
$1,221
Curonix LLC
$908
Collegium Pharmaceutical, Inc.
$189
Nevro Corp.
$178
SPR Therapeutics, Inc
$171
MML US, Inc.
$147
Abbott Laboratories
$140
VERTEX PHARMACEUTICALS INCORPORATED
$131
Vertos Medical, Inc.
$89
Boston Scientific Corporation
$77
PROTEGA PHARMACEUTIALS INC
$33
SCILEX PHARMACEUTICALS INC.
$33
Grifols USA, LLC
$32
MDD US Operations, LLC
$25
Indivior Inc.
$23
Averitas Pharma Inc.
$19
IBSA Pharma Inc.
$18
Lundbeck LLC
$16
Top 3 companies account for 73.0% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$4,904
Nevro Corp.
$4,033
Boston Scientific Corporation
$1,849
Spinal Simplicity, LLC
$1,439
BOSTON SCIENTIFIC CORPORATION
$1,386
SI-BONE, INC.
$1,246
Curonix LLC
$1,045
Collegium Pharmaceutical, Inc.
$927
SI-BONE, Inc.
$515
SPR Therapeutics, Inc
$512
Amgen Inc.
$478
US WorldMeds, LLC
$470
Medtronic, Inc.
$311
Biohaven Pharmaceutical Holding Company Ltd.
$253
Novartis Pharmaceuticals Corporation
$246
Vertos Medical, Inc.
$237
Teva Pharmaceuticals USA, Inc.
$234
PFIZER INC.
$219
Daiichi Sankyo Inc.
$183
ABBVIE INC.
$159
Scilex Pharmaceuticals Inc.
$151
Biohaven Pharmaceuticals, Inc.
$149
Sentynl Therapeutics, Inc.
$147
MML US, Inc.
$147
Vanda Pharmaceuticals Inc.
$141
VERTEX PHARMACEUTICALS INCORPORATED
$131
AbbVie Inc.
$116
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$106
Mallinckrodt LLC
$102
Takeda Pharmaceuticals U.S.A., Inc.
$95
SCILEX PHARMACEUTICALS INC.
$73
Grifols USA, LLC
$60
Lilly USA, LLC
$60
Allergan, Inc.
$50
UPSHER-SMITH LABORATORIES LLC
$43
ASSERTIO THERAPEUTICS, Inc.
$43
ARBOR PHARMACEUTICALS, INC.
$40
Virtus Pharmaceuticals LLC
$40
Egalet US Inc
$40
Flexion Therapeutics, Inc.
$38
USWM, LLC
$37
AstraZeneca Pharmaceuticals LP
$37
PROTEGA PHARMACEUTIALS INC
$33
Kaleo, Inc.
$31
Horizon Therapeutics plc
$30
Assertio Therapeutics, Inc.
$28
Kyowa Kirin, Inc.
$25
MDD US Operations, LLC
$25
Banner Life Sciences, LLC
$24
Pacira Therapeutics, Inc.
$24
Indivior Inc.
$23
RedHill Biopharma Inc.
$21
DePuy Synthes Sales Inc.
$20
Averitas Pharma Inc.
$19
IBSA Pharma Inc.
$18
Supernus Pharmaceuticals, Inc.
$18
Lundbeck LLC
$16
Arbor Pharmaceuticals, Inc.
$16
Zyla Life Sciences
$16
ACADIA Pharmaceuticals Inc
$14
Alkermes, Inc.
$14
Amneal Pharmaceuticals LLC
$13
Zyla Life Sciences, Inc.
$12
Merck Sharp & Dohme Corporation
$11
Impax Laboratories, Inc.
$11
Purdue Pharma L.P.
$11
Promius Pharma LLC
$11
Top 3 companies account for 46.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · APOKYN · ARYMO ER · AUSTEDO · Aimovig · Amitiza · Axium INS DRG IPG · BAFIERTAM · BELSOMRA · BOTOX · Belbuca · Cambia · DUEXIS · ELYXYB - celecoxib · EMBEDA · EMGALITY · Evzio · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · Gamunex-C · Gocovri · Gralise · HA MINUTEMAN G3-R · HETLIOZ · Horizant · IFUSE IMPLANT · IFUSE IMPLANT SYSTEM · INFINITY · INTELLIS · INTELLIS ADAPTIVESTIM · IONICRF · LACTULOSE · LEVORPHANOL TARTRATE · LIBERTY SI · LYRICA · Levorphanol · Levorphanol Tartrate · Lucemyra · Lucemyra/Lofexidine · MONOVISC · MOVANTIK · Morphabond ER · Movantik · NUPLAZID · NURTEC ODT · Neuromodulation Dspsbls and Accs · Nourianz · OCTRODE · Omnia · PENNSAID · PENTA · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Penta SCS Leads · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · QUTENZA · RELISTOR · ROXYBOND · RYTARY · ReActiv8 · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUBLOCADE · SYMPROIC · Senza · Senza Spinal Cord Stimulation System · Superion Indirect Decompression System · TOSYMRA · TROKENDI XR · Tirosint · Trintellix · UBRELVY · VYEPTI · Vivitrol · WaveWriter Alpha Prime 16 · XIFAXAN · XTAMPZA · XTAMPZAER · Xadago · Xtampza ER · ZEMBRACE SYMTOUCH · ZEVO · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zilretta · Zipsor · iFuse Implant · mild Device Kit
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Physical medicine & rehabilitations in nearby ZIP areas
54
County median income
$71,175
Nearest hospital to ZIP centroid (approximate)
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
5.6 mi
5.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Salcedo is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Salcedo experienced with normal saline infusion, 250 cc?
Based on Medicare claims data, Dr. Salcedo performed 374 normal saline infusion, 250 cc services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Salcedo receive payments from pharmaceutical companies?
Yes. Dr. Salcedo received a total of $22,977 from 67 companies across 817 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Salcedo's costs compare to other physical medicine & rehabilitations in Williamsville?
Dr. Salcedo's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Salcedo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Physical Medicine & Rehabilitation
Common procedures, typical costs, and what industry payments mean in physical medicine & rehabilitation.
Same specialty & city
Physical Medicine & Rehabilitations in Williamsville
Browse physical medicine & rehabilitations in Williamsville ranked by procedure volume and transparency data.
Highest volume
Top Physical Medicine & Rehabilitations in NY
Physical medicine & rehabilitations ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Physical Medicine & Rehabilitations in NY
Which NY physical medicine & rehabilitations receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology